Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cook Biotech Incorporated Sues Competitor Alleging Patent Infringement.


Business Editors & Health/Medical Writers

BIOWIRE2K

WEST LAFAYETTE, Ind.--(BW HealthWire)--June 12, 2002

Cook Biotech Incorporated has filed a patent infringement lawsuit against Organogenesis organogenesis /or·ga·no·gen·e·sis/ (or?gah-no-jen´e-sis) the origin and development of organs.organogenet´ic

or·gan·o·gen·e·sis
n.
The formation and development of the organs of living things.
 Inc. of Canton, Massachusetts, charging Organogenesis with infringement of U.S. Patent No. 5,573,784 directed to a graft for promoting autogenous autogenous /au·tog·e·nous/ (aw-toj´e-nus) autologous.

au·tog·e·nous or au·to·gen·ic
adj.
1. Of or relating to autogenesis; self-generating.

2.
 tissue growth.

Cook Biotech, which is a licensee under the patent and has the right to sue for infringement, is seeking damages and injunctive relief. Cook Biotech filed the complaint May 3, 2002 in the U.S. District Court for the Southern District of Indiana in Indianapolis, Indiana. The suit alleges that Organogenesis has been and is infringing the patent by selling tissue graft material covered by the patent.

Established in 1995, Cook Biotech, a Cook Group company, produces tissue-engineered biomaterials and is actively developing extracellular matrix (ECM (1) (Enterprise Change Management) See version control and configuration management.

(2) (Error Correcting Mode) A Group 3 fax capability that can test for errors within a row of pixels and request retransmission.
) technologies for numerous medical purposes. Currently, the Cook companies market several products utilizing Cook Biotech's patented SIS technology, a tissue-engineered matrix derived from porcine small intestinal submucosa Small intestinal submucosa (SIS) is a common, non-immunogenic material used in several clinical applications. Some uses under investigation include a scaffold for intervertebral disc regeneration.  (SIS). This tissue-engineered biomaterial forms a natural, acellular acellular /acel·lu·lar/ (a-sel´u-ler) not cellular in structure.

a·cel·lu·lar
adj.
1. Containing no cells; not made of cells.

2. Devoid of cells; noncellular.
 scaffold that forms a framework for tissue repair. SIS technology biomaterials are being marketed by the Cook companies for applications in general surgery, urology and gynecological gynecological /gy·ne·co·log·i·cal/ (-kah-loj´i-k'l) gynecologic.  procedures, and for the management of venous-stasis, diabetic, pressure, and chronic vascular ulcers.

With international headquarters in Bloomington, Ind., privately held COOK(R) (www.cookgroup.com) is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, Cook has created innovative technologies for stents and stent-grafts, catheters, wire guides, introducer needles and sheaths, embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun)
1. the process or condition of becoming an embolus.

2. therapeutic introduction of a substance into a vessel in order to occlude it.
 coils, tissue-engineered medical biomaterials, vena cava filters, implanted cardiac lead extraction equipment and other minimally invasive medical devices.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:Cook Biotech Incorporated Sues Competitor Alleging Patent Infringement.
Publication:Business Wire
Geographic Code:1USA
Date:Jun 12, 2002
Words:282
Previous Article:Aspen Appoints New Chief Financial Officer.
Next Article:Williams Unit Improves Gas Supply Diversity With New East Cameron Connection.
Topics:



Related Articles
The patent files.
The Value of Intellectual Property.
Consumer class actions follow suits by generic drug makers against brand-name companies.
SEAGATE FILES PATENT LAWSUIT AGAINST STORAGE COMPUTER CORP.
3D SYSTEMS SUIT CLAIMS HIGH-TECH PATENT VIOLATIONS.
Data storage makers duke it out. (Up front: news, trends & analysis).
Speedline and EKRA enter legal battle.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles